Optimal Dose of Spinal Bupivacaine on Maternal and Fetal Outcomes in Parturients Undergoing Combined Technique for Labor Analgesia: A Randomized Double Blinded Prospective Study
Authors:
- Barbara S. OrlandoBOBarbara S. Orlando
- Deborah SteinDSDeborah Stein
- Jacqueline DonovanJDJacqueline Donovan
- Jason WhiteJWJason White
- Ivan BandovicIBIvan Bandovic
- Pradeepan AnanthasingamPAPradeepan Ananthasingam
- Hung-Mo LinHLHung-Mo Lin
- Julio MarencoJMJulio Marenco
- Migdalia SaloumMSMigdalia Saloum
- Bryan MahoneyBMBryan Mahoney
- Dimitri KassapidisDKDimitri Kassapidis
- Jonathan EpsteinJEJonathan Epstein
Open Access
- 18 May 2023
- journal article
- research article
- Published by Levy Library Press in Journal of Scientific Innovation in Medicine
- Vol. 6 (1)
Abstract
Study Objectives: Maternal hypotension and fetal bradycardia (FB) are recognized complications of combined spinal epidural. Our purpose was to ascertain which of 3 common doses of spinal bupivacaine results in optimal analgesia with minimal side effects, assuming the lowest dose fills all criteria. Design: Prospective, randomized clinical trial. Setting: Labor and Delivery Unit of 514-bed urban teaching hospital. Patients, Interventions and Measurements: Patients were assigned to receive an intrathecal dose of 20 mcg of fentanyl with either 2.5 mg, 1.66 mg, or 1.25 mg of isobaric bupivacaine. Visual Analog Scale (VAS) Pain Score, fetal heart rate (FHR), maternal blood pressure (BP), number of hypotensive episodes, doses of vasopressors, nitroglycerin and mode of delivery were recorded at various time points. Main results: 164 patients were enrolled: 66 receiving 1.25 mg, 50 in the 1.66 mg group and 48 in the 2.5 mg. At 6 and 10 minutes, we recorded in the 1.66 mg group: 4.7% and 4.6%, 18.9% and 23.9% fewer hypotensive episodes compared with the 1.25 mg and the 2.5 mg groups respectively and significantly more hypotensive episodes in the 2.5 mg group (p = 0.025 and 0.019 respectively). There was no statistical difference in vasopressors use, mode of delivery or FB. The VAS decreased equally by an average of 7–10 points among all groups. Conclusion: The 1.66 mg spinal dose was associated with the least hypotensive episodes and equivalent pain relief as the 2.5 mg. The 1.25 mg and 1.66 mg doses allowed for adequate BP and FHR stability. Clinical Trial: Study registered on the ClinicalTrial.gov website under the NCT number NCT02159807.Keywords
This publication has 14 references indexed in Scilit:
- Labor Analgesia Onset With Dural Puncture Epidural Versus Traditional Epidural Using a 26-Gauge Whitacre Needle and 0.125% Bupivacaine Bolus: A Randomized Clinical TrialAnesthesia & Analgesia, 2018
- Synergistic Interaction between Fentanyl and Bupivacaine Given Intrathecally for Labor AnalgesiaAnesthesiology, 2014
- Pain management for women in labour: an overview of systematic reviewsCochrane Database of Systematic Reviews, 2012
- Practice Bulletin No. 116: Management of Intrapartum Fetal Heart Rate TracingsObstetrics & Gynecology, 2010
- Determination of the ED95 for intrathecal plain bupivacaine combined with fentanyl in active laborInternational Journal of Obstetric Anesthesia, 2007
- Minimum Local Analgesic Doses of Ropivacaine, Levobupivacaine, and Bupivacaine for Intrathecal Labor AnalgesiaAnesthesiology, 2005
- Incidence and characteristics of failures in obstetric neuraxial analgesia and anesthesia: a retrospective analysis of 19,259 deliveriesInternational Journal of Obstetric Anesthesia, 2004
- Reliability of the Visual Analog Scale for Measurement of Acute PainAcademic Emergency Medicine, 2001
- Minimum Local Analgesic Dose of Intrathecal Bupivacaine in Labor and the Effect of Intrathecal FentanylAnesthesiology, 2001
- Combined spinal–epidural analgesia in labour: comparison of two doses of intrathecal bupivacaine with fentanylBritish Journal of Anaesthesia, 1999